arrow
R

Ravi Shankar Prasad Singh

Pfizer Research and Development
H指数:22
被引数:3,275

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study

一项多部分I期研究,以评估伊布扎特雷韦尔在健康受试者中的安全性和药代动力学,并为剂量探索研究选择剂量

2026-07-110
OAAI
Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group study
2021-03-0122
PRE
Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses)
2018-04-0111
OAAI